Innocan Pharma Announces Private Placement Offering of a Debenture Unit to its Largest Shareholder, Tamar Innovest PressReach · Feb 28, 2025
MTL Cannabis Corp. Reports Third Quarter Results with $25.6 Million of Revenue PressReach · Feb 28, 2025
Ascend Wellness Announces Grand Reopening of Detroit Dispensary, Its 38th Retail Location in the Nation, on February 28th PressReach · Feb 27, 2025
Is It Legal To Purchase Delta-8 and Delta-9 Products in Kansas? | Criminal Defense Lawyers, Wichita, KS PressReach · Feb 27, 2025
VIST Labs Announces Strategic Partnership with Paralab to Expand European Distribution of Cannabis Decontamination and Packaging Solutions PressReach · Feb 27, 2025
SNDL to Announce Fourth Quarter 2024 and Full Year 2024 Financial Results on March 18, 2025 PressReach · Feb 26, 2025
DeFloria Receives Investigational New Drug Application Clearance from FDA for Phase 2 Clinical Trial of AJA001, an Oral Cannabinoid Drug Being Developed for the Treatment of Autism Spectrum Disorder (ASD) PressReach · Feb 25, 2025
Charlotte's Web Announces DeFloria to enter Phase 2 FDA Clinical Trial for Autism Spectrum Disorder Treatment PressReach · Feb 25, 2025
Tempter's Elevated Seltzers Powered WSWA Access LIVE 2025 with Country Music and Innovation PressReach · Feb 22, 2025
